指南与共识介入外周血管技术与安全DSA

特定介入放射学操作前输注血制品:标准化方案的制定、应用与监测

Administering Blood Products Before Selected Interventional Radiology Procedures: Developing, Applying, and Monitoring a Standardized Protocol.
PubMed 文献 · J Am Coll Radiol · 2017-09-28

单中心学术医院自2008年12月起实施限制性术前血小板和/或新鲜冰冻血浆输注指南,采用精益六西格玛方法比较2008年、2010年和2015年1月至10月的输血率、出血并发症及适当输血比例。适当血制品输注比例从2008年58%升至2010年76%(P=0.021),2015年进一步升至88%(P=0.051),2008至2015年总体改善显著(P<0.001),三组出血并发症率均极低。

要点

  • 术前血小板≤50,000或INR≥1.7分别符合输注血小板或新鲜冰冻血浆标准。
  • 适当血制品输注比例从2008年58%升至2010年76%(P=0.021),2015年达88%(P=0.051)。
  • 2008至2015年适当输注比例总体改善显著(P<0.001),出血并发症率三组均极低。

核心结论

  • 限制性术前血小板和新鲜冰冻血浆输注指南可持续降低总体血制品输注率并提高适当输注比例,且不增加出血并发症率。

研究设计与样本

  • 单中心学术医院质量改进项目,基于精益六西格玛方法,比较2008年、2010年和2015年1月至10月介入放射学操作前血制品输注情况。

诊断标准与关键数值

  • 术前血小板计数≤50,000符合输注血小板标准。
  • 术前INR≥1.7符合输注新鲜冰冻血浆标准。
  • 适当血制品输注比例:2008年58% vs 2010年76%(P=0.021)。
  • 适当血制品输注比例:2010年76% vs 2015年88%(P=0.051)。
  • 适当血制品输注比例:2008年58% vs 2015年88%(P<0.001)。

临床应用与阅片要点

  • 本研究中心的做法是介入放射学操作前按限制性指南评估血小板和新鲜冰冻血浆输注指征。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To apply and monitor a single institution's adherence to internally established guidelines for the preoperative administration of platelets and/or fresh frozen plasma (FFP) before a specified subset of minimally invasive interventional radiology (IR) procedures.

MATERIALS AND METHODS: Beginning in December 2008, we implemented a set of restrictive guidelines for preoperative platelet and/or FFP administration before IR procedures at a single academic hospital. Basing our program on the methodology of Lean Six Sigma, we compared the number and appropriateness of transfusions between the months of January and October in 2008 (prepolicy), again in 2010 (postpolicy), and finally in 2015 (follow-up). Patients with a platelet count less than or equal to 50,000 or an international normalized ratio greater than or equal to 1.7 met criteria for receiving platelets or FFP, respectively, before their IR procedure. For all three periods, we compared the rates of transfusion, hemorrhagic complications, and proportion of appropriate versus inappropriate blood product administration (BPA) per our guidelines.

RESULTS: There was a significant increase in the number of appropriate BPAs between 2008 and 2010 from 58% to 76% (P = .021). Between 2010 and 2015, the rate trended up further, from 76% to 88% (P = .051). Overall, between 2008 and 2015, the improvement from 58% to 88% was significant (P < .001). The rate of hemorrhagic complications was extremely low in all three groups.

CONCLUSION: Restrictive guidelines for receiving platelets and FFP administrations before IR procedures can sustainably decrease the rate of overall BPA while increasing the proportion of appropriate BPA without impacting the rate of hemorrhagic complications.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Hoang NS, Kothary N, Saharan S, et al. Administering Blood Products Before Selected Interventional Radiology Procedures: Developing, Applying, and Monitoring a Standardized Protocol. J Am Coll Radiol. 2017. PMID: 28964688. doi:10.1016/j.jacr.2017.07.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。